Kalbe Farma Future Growth
Future criteria checks 1/6
Kalbe Farma is forecast to grow earnings and revenue by 10.7% and 6.7% per annum respectively. EPS is expected to grow by 10.4% per annum. Return on equity is forecast to be 14.6% in 3 years.
Key information
10.7%
Earnings growth rate
10.4%
EPS growth rate
Pharmaceuticals earnings growth | 20.9% |
Revenue growth rate | 6.7% |
Future return on equity | 14.6% |
Analyst coverage | Good |
Last updated | 15 Mar 2024 |
Recent future growth updates
No updates
Recent updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 35,205,131 | 3,595,065 | 2,106,999 | 4,569,600 | 12 |
12/31/2024 | 33,013,586 | 3,459,670 | 2,944,315 | 3,730,860 | 15 |
12/31/2023 | 30,921,873 | 2,828,284 | 3,367,000 | 3,103,580 | 14 |
9/30/2023 | 30,312,738 | 2,961,621 | 1,171,758 | 2,172,143 | N/A |
6/30/2023 | 30,237,846 | 3,274,258 | 494,336 | 1,474,180 | N/A |
3/31/2023 | 29,786,958 | 3,403,045 | 240,749 | 1,135,214 | N/A |
12/31/2022 | 28,933,503 | 3,382,210 | 421,107 | 1,271,889 | N/A |
9/30/2022 | 28,344,270 | 3,381,401 | 313,176 | 1,099,074 | N/A |
6/30/2022 | 27,765,354 | 3,323,285 | 1,692,938 | 2,364,331 | N/A |
3/31/2022 | 27,261,485 | 3,302,038 | 2,005,220 | 2,696,856 | N/A |
12/31/2021 | 26,261,195 | 3,183,621 | 1,833,191 | 2,825,946 | N/A |
9/30/2021 | 25,115,512 | 2,993,591 | 2,996,737 | 4,002,944 | N/A |
6/30/2021 | 23,878,570 | 2,843,018 | 2,400,178 | 3,479,716 | N/A |
3/31/2021 | 23,332,456 | 2,780,456 | 2,813,800 | 3,965,497 | N/A |
12/31/2020 | 23,112,655 | 2,733,260 | 3,145,947 | 4,221,550 | N/A |
9/30/2020 | 22,902,507 | 2,618,701 | 2,045,808 | 3,469,847 | N/A |
6/30/2020 | 23,059,326 | 2,636,125 | 1,457,616 | 3,152,554 | N/A |
3/31/2020 | 23,063,580 | 2,580,962 | 987,889 | 2,903,915 | N/A |
12/31/2019 | 22,633,476 | 2,506,765 | 520,042 | 2,502,969 | N/A |
9/30/2019 | 22,222,813 | 2,568,165 | 650,143 | 2,414,095 | N/A |
6/30/2019 | 21,872,440 | 2,499,430 | 1,101,349 | 2,831,599 | N/A |
3/31/2019 | 21,424,910 | 2,462,761 | 1,074,438 | 2,634,606 | N/A |
12/31/2018 | 21,074,306 | 2,457,129 | 1,397,745 | 2,770,776 | N/A |
9/30/2018 | 20,770,524 | 2,428,630 | 1,065,101 | 2,533,889 | N/A |
6/30/2018 | 20,496,345 | 2,403,213 | 717,276 | 2,106,264 | N/A |
3/31/2018 | 20,298,678 | 2,404,792 | 841,802 | 2,108,688 | N/A |
12/31/2017 | 20,182,120 | 2,403,606 | 772,834 | 2,008,317 | N/A |
9/30/2017 | 20,087,979 | 2,376,474 | 898,047 | 1,957,670 | N/A |
6/30/2017 | 19,884,741 | 2,369,779 | N/A | 2,082,448 | N/A |
3/31/2017 | 19,722,837 | 2,324,750 | N/A | 2,233,931 | N/A |
12/31/2016 | 19,374,231 | 2,299,735 | N/A | 2,159,833 | N/A |
9/30/2016 | 19,135,808 | 2,207,683 | N/A | 2,402,394 | N/A |
6/30/2016 | 18,723,481 | 2,087,332 | N/A | 2,349,076 | N/A |
3/31/2016 | 18,190,514 | 2,038,815 | N/A | 2,171,154 | N/A |
12/31/2015 | 17,887,464 | 2,004,237 | N/A | 2,427,642 | N/A |
9/30/2015 | 17,737,870 | 2,078,487 | N/A | 2,277,535 | N/A |
6/30/2015 | 17,708,558 | 2,136,225 | N/A | 2,314,557 | N/A |
3/31/2015 | 17,548,723 | 2,101,577 | N/A | 2,504,167 | N/A |
12/31/2014 | 17,368,533 | 2,066,022 | N/A | 2,316,126 | N/A |
9/30/2014 | 17,320,906 | 2,040,142 | N/A | 1,863,426 | N/A |
6/30/2014 | 16,960,755 | 1,990,437 | N/A | 1,436,411 | N/A |
3/31/2014 | 16,578,629 | 1,968,549 | N/A | 1,092,379 | N/A |
12/31/2013 | 16,002,131 | 1,919,508 | N/A | 927,164 | N/A |
9/30/2013 | 15,382,085 | 1,857,427 | N/A | 1,288,934 | N/A |
6/30/2013 | 14,813,587 | 1,848,614 | N/A | 1,441,462 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PTKF.Y's forecast earnings growth (10.7% per year) is above the savings rate (2.3%).
Earnings vs Market: PTKF.Y's earnings (10.7% per year) are forecast to grow slower than the US market (13.4% per year).
High Growth Earnings: PTKF.Y's earnings are forecast to grow, but not significantly.
Revenue vs Market: PTKF.Y's revenue (6.7% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: PTKF.Y's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PTKF.Y's Return on Equity is forecast to be low in 3 years time (14.6%).